Fintel reports that on October 31, 2025, HC Wainwright & Co. maintained coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts.

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Discover why Alexandria Real Estate Equities is a top REIT pick for long-term gains and dividends after a price dip. Click ...

Shares of pharmaceutical company AbbVie (NYSE:ABBV) fell 3.9% in the afternoon session after the company reported third-quarter results that were overshadowed by a steep drop in profitability and a ...

Return on Assets (ROA): Axsome Therapeutics's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -7.76%, the company may face hurdles in ...

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 740 in its ...

Return on Equity (ROE): Liquidia's ROE is below industry standards, pointing towards difficulties in efficiently utilizing ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...